Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Active, not recruiting1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting133%
not_yet_recruiting133%
recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruiting

A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors

NCT07387874
recruiting

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

NCT07309094
not_yet_recruitingnot_applicable

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

NCT06135584

Clinical Trials (3)

Showing 3 of 3 trials
NCT07387874

A Real-World Study of Trastuzumab Rezetecan in HER2+ Solid Tumors

Active Not Recruiting
NCT07309094

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Recruiting
NCT06135584Not Applicable

Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies

Not Yet Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3